Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.55 USD | -2.03% | -.--% | -9.45% |
05-31 | SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%) | |
05-14 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.45% | 10.99B | - | ||
+13.73% | 130B | A- | ||
-4.33% | 8.35B | C | ||
+41.80% | 5.67B | B+ | ||
-21.94% | 4.72B | C | ||
+7.81% | 3.42B | C- | ||
-10.26% | 2.76B | B- | ||
-10.29% | 2.11B | - | - | |
-13.58% | 1.92B | - | ||
-27.77% | 1.68B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- SNNUF Stock
- Ratings Smith & Nephew Plc